CAJ | 학술논문

从药品安全现状的不容乐观性,政府治理的局限性以及社会共治的优势性三方面提出构建以政府、企业、行业协会、媒体及公众为参与主体的、联合联动的“五位一体”药品安全社会共治格局的必要性,分析了基于社会共治格局视角下的药品安全治理的现实困境,提出通过完善法律和制度体系,改革治理权力配置机制,完善社会治理驱动机制,创新治理手段、提高治理能力等措施加强“五位一体”药品安全社会共治格局建设.
종약품안전현상적불용악관성,정부치리적국한성이급사회공치적우세성삼방면제출구건이정부、기업、행업협회、매체급공음위삼여주체적、연합련동적“오위일체”약품안전사회공치격국적필요성,분석료기우사회공치격국시각하적약품안전치리적현실곤경,제출통과완선법률화제도체계,개혁치리권력배치궤제,완선사회치리구동궤제,창신치리수단、제고치리능력등조시가강“오위일체”약품안전사회공치격국건설.
In this consideration,the paper described the imperatives of drug safety,constraints of governance by the government,and advantages of social co-governance,proposing the necessity to establish a " Five-in-One" (referring to the involvement of the government,enterprises,industry associations,media and the public) drug safety social co-governance.In its analysis of the present dilemma o[drug safety governance,the authors proposed such measures as perfecting legal and institutional system,reforming governmental power allocation mechanism,improving the incentive mechanism,innovating governance means and improving social governance ability,for the purpose of enhancing such a co-governance pattern.